How can we tackle the overuse of antibiotics in low- and middle-income countries?

Area of Science:

• Global Health
• Infectious Diseases
• Antimicrobial Resistance

Background:

• Antibiotic overuse is a critical global health issue, particularly impacting low- and middle-income countries (LMICs).
• LMICs face challenges including limited access to quality healthcare, weak regulatory frameworks, and insufficient diagnostic capabilities, exacerbating antibiotic misuse.
• The non-prescription sale of antibiotics and inadequate stewardship programs contribute significantly to the problem.

Purpose of the Study:

• To highlight the multifaceted challenges of antibiotic overuse in LMICs.
• To explore potential solutions and strategies for mitigating antibiotic overuse in these regions.
• To emphasize the need for a comprehensive, collaborative approach to combat this global health concern.

Main Methods:

• This perspective piece synthesizes existing knowledge and expert opinion on antibiotic overuse in LMICs.
• It analyzes key contributing factors such as healthcare infrastructure, diagnostic limitations, and regulatory deficiencies.
• The discussion includes potential interventions like point-of-care diagnostics, vaccine utilization, and improved hygiene.

Main Results:

• Weak healthcare systems, limited diagnostic tools, and poor regulation are primary drivers of antibiotic overuse in LMICs.
• Effective solutions require strengthening healthcare infrastructure, enhancing diagnostic access, and implementing robust regulatory measures.
• The expanded use of vaccines and improved sanitation are crucial complementary strategies.

Conclusions:

• A multi-pronged strategy involving healthcare professionals, policymakers, researchers, and educators is essential.
• Improving healthcare access, diagnostics, and regulatory oversight are critical steps.
• International collaboration, education, and promoting responsible antibiotic use are vital for addressing antibiotic overuse in LMICs.